Molecular analysis of cell‐free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
Jie Zhang(Hefei University of Technology), Henghui Zhang(Capital Medical University), Wenbo Han(Northwest A&F University), Yang Wang(Kunming University of Science and Technology), Jian Fang(Peking University), Xiaoling Chen(Peking University), Di Wu(Sun Yat-sen University), Jianfei Wang(First Affiliated Hospital of Wannan Medical College), Guangming Tian(Peking University), Jun Nie(Peking University), Sen Han(Peking University), Xiangjuan Ma(Peking University), Ziran Zhang(Peking University), Ling Dai(Peking University), Jieran Long(Peking University), Weiheng Hu(Peking University), Chen Tian(Nanjing University), Fang Lv(Liaoning Normal University)
Cited by 11
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Edge Provisioning with Flexible Server Placement
|IEEE Transactions on Parallel and Distributed Systems|2016|139
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128